Trials, Data Needed To Guide Biosimilar Adoption

20-02-2014 Clinical Oncology NewsComments (0)


Effectively integrating biosimilar drugs into the U.S. market will require careful collaboration between manufacturers and regulators, according to clinicians who spoke during a recent web conference hosted by the Institute for Safe Medication ...

Read more on Clinical Oncology News

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top